Innovacell (TKS: 504A)

Tokyo, Japan · Publicly Held

Innovacell Inc is engaged in the development, manufacturing, and sale of regenerative medicine products for the treatment of conditions including fecal and urinary incontinence. Innovacell (TKS: 504A) is based in Tokyo, Japan. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $364 million (Feb 2026). It has raised $193 million.

Last price · $/share

—

Implied valuation

$364.2M

Total raised

$193.4M

Last round

—

How much has Innovacell (TKS: 504A) raised?

$193.4Macross 0 recorded rounds

Free account

More of Innovacell (TKS: 504A) with a free account

·The complete investor list: 26 names
·Watch Innovacell (TKS: 504A): the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Innovacell (TKS: 504A) investors

26 investors are on record for Innovacell (TKS: 504A), including SBI Investment, UntroD, HiJoJo Partners and Happiness Capital.

For fundraisers

Raising for a company like Innovacell (TKS: 504A)?

26 investors have backed Innovacell (TKS: 504A).

See all 26 investors →

Frequently asked about Innovacell (TKS: 504A)

How much has Innovacell (TKS: 504A) raised?: Innovacell (TKS: 504A) has raised $193.4M in total across 0 recorded funding rounds.